Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells.

Zeng L, Holly JM, Perks CM.

Front Endocrinol (Lausanne). 2014 May 7;5:61. doi: 10.3389/fendo.2014.00061. eCollection 2014.

2.

(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.

Farabegoli F, Barbi C, Lambertini E, Piva R.

Cancer Detect Prev. 2007;31(6):499-504.

PMID:
18061364
3.
6.

Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase.

Moradzadeh M, Hosseini A, Erfanian S, Rezaei H.

Pharmacol Rep. 2017 Oct;69(5):924-928. doi: 10.1016/j.pharep.2017.04.008. Epub 2017 Apr 13.

PMID:
28646740
7.

Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells.

Pan X, Zhao B, Song Z, Han S, Wang M.

J Pharmacol Sci. 2016 Feb;130(2):85-93. doi: 10.1016/j.jphs.2015.12.003. Epub 2015 Dec 15.

8.

Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.

Chisholm K, Bray BJ, Rosengren RJ.

Anticancer Drugs. 2004 Oct;15(9):889-97.

PMID:
15457130
9.

Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.

Thangapazham RL, Passi N, Maheshwari RK.

Cancer Biol Ther. 2007 Dec;6(12):1938-43. Epub 2007 Sep 1.

PMID:
18059161
10.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
11.

Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.

Shimizu M, Shirakami Y, Moriwaki H.

Int J Mol Sci. 2008 Jun;9(6):1034-49. doi: 10.3390/ijms9061034. Epub 2008 Jun 20.

12.

Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.

Dickinson D, Yu H, Ohno S, Thomas C, Derossi S, Ma YH, Yates N, Hahn E, Bisch F, Yamamoto T, Hsu S.

Inflamm Allergy Drug Targets. 2014 Feb;13(1):15-24.

13.

Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.

Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, Wang F, Liu K, Liu Q, Yang C, Yu P, Huang Y, Wang S, Jiang P, Qu Z, Luan J, Duan H, Zhang L, Hou A, Jin S, Hsieh TC, Wu E.

Curr Mol Med. 2012 Feb;12(2):163-76.

14.

Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.

Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE.

PLoS One. 2013 Sep 11;8(9):e73464. doi: 10.1371/journal.pone.0073464. eCollection 2013.

15.

Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling.

Singh T, Katiyar SK.

Toxicol Appl Pharmacol. 2013 Dec 1;273(2):418-24. doi: 10.1016/j.taap.2013.09.021. Epub 2013 Oct 3.

16.

High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.

Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N.

Endocr Relat Cancer. 2007 Sep;14(3):691-702.

17.

Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.

Sah JF, Balasubramanian S, Eckert RL, Rorke EA.

J Biol Chem. 2004 Mar 26;279(13):12755-62. Epub 2003 Dec 29.

18.
20.

Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.

Hastak K, Agarwal MK, Mukhtar H, Agarwal ML.

FASEB J. 2005 May;19(7):789-91. Epub 2005 Mar 11.

PMID:
15764647

Supplemental Content

Support Center